In colorectal cancer (CRC), high PRDX1 expression correlates with tumor invasiveness, metastasis, and chemotherapy resistance, and its role in immune evasion and chemotherapy resistance makes it a potential therapeutic target (Song et al., 2024). Here, PRDX1 is linked to colorectal cancer.